Limitation to the use of the urinary S‐/R‐mephenytoin ratio in pharmacogenetic studies.
Open Access
- 1 March 1991
- journal article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 31 (3) , 350-352
- https://doi.org/10.1111/j.1365-2125.1991.tb05542.x
Abstract
The reproducibility of the S‐/R‐mephenytoin ratio was examined in urines stored at ‐20 degrees C over 2 years. Large changes in this ratio were observed in some urine samples stored for only a few months under these conditions. The changes observed in the S‐/R‐mephenytoin ratio are attributed to the decomposition of an acid labile metabolite of S‐mephenytoin which is eliminated in the urine. The instability of this metabolite makes it desirable to process urine shortly after its collection in order to avoid inaccurate phenotype assignments based upon the urinary S‐/R‐mephenytoin ratio. If rapid processing of urines is impractical, additional methods are described for preventing improper phenotype assignment of subjects.Keywords
This publication has 12 references indexed in Scilit:
- Rapid screening for polymorphisms in dextromethorphan and mephenytoin metabolism.British Journal of Clinical Pharmacology, 1990
- S-mephenytoin hydroxylation phenotypes in a Swedish population determined after coadministration with debrisoquinClinical Pharmacology & Therapeutics, 1989
- Mephenytoin and sparteine oxidation: genetic polymorphisms in Denmark.British Journal of Clinical Pharmacology, 1989
- Mephenytoin hydroxylation polymorphism: Characterization of the enzymatic deficiency in liver microsomes of poor metabolizers phenotyped in vivoClinical Pharmacology & Therapeutics, 1985
- Interethnic differences in genetic polymorphism of debrisoquin and mephenytoin hydroxylation between Japanese and Caucasian populationsClinical Pharmacology & Therapeutics, 1985
- Mephenytoin hydroxylation deficiency in Caucasians: Frequency of a new oxidative drug metabolism polymorphismClinical Pharmacology & Therapeutics, 1984
- Mephenytoin hydroxylation deficiency: Kinetics after repeated dosesClinical Pharmacology & Therapeutics, 1984